Elevated Down Syndrome Incidence And Maternal Age Is Fueling Growth In Non-Invasive Prenatal Testing Market Emerges as a Core Driver of the Non-invasive Prenatal Testing Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Non-invasive Prenatal Testing Market Through 2025?
Over the past few years, the non-invasive prenatal testing market has seen a swift expansion. The market is projected to surge from a size of $5.48 billion in 2024 to $6.28 billion in 2025 with a compound annual growth rate (CAGR) of 14.7%. Factors such as heightened accuracy, diminished risk, increase in maternal age, burgeoning awareness, and clinical guidelines, are considered responsible for this growth in the historic period.

What's the Projected Size of the Global Non-invasive Prenatal Testing Market by 2029?
The market size for non-invasive prenatal testing is projected to experience swift expansion in the upcoming years, with expectations to hit the $10.95 billion mark in 2029. This represents a compound annual growth rate (CAGR) of 14.9%. Key drivers of growth for this forecasted period include increased testing options, more accessibility, aging maternal demographics, the capacity to detect fetal anomalies, and advancements in telemedicine and digital health practices. Notable trends for this period encompass broader test panels, increased use of non-invasive prenatal testing (nipt), technological progress, and the non-invasive diagnosis of fetal aneuploidy (nifad).

View the full report here:
https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

Top Growth Drivers in the Non-invasive Prenatal Testing Industry: What's Accelerating the Market?
The surge in Down syndrome prevalence is a significant determinant propelling the non-invasive prenatal testing market, given the rise in average maternal age causing concerns about fetal growth safety. Down syndrome, a chromosome malfunction resulting from a cell division error resulting in an additional chromosome 21, can impact the cognitive and physical development of the fetus. Offering no harm to the baby or mother, and bringing no miscarriage risk because of its non-invasive nature, NIPT screening tests can identify over 99% of Down Syndrome cases. As per the National Down Syndrome Society and Centres for Disease Control and Prevention, 1 in 700 babies born in the USA are diagnosed with Down syndrome, and mothers of advanced age account for 80% of Down syndrome births. The elevated probability of older women giving birth to babies with Down syndrome fuels the expansion of the non-invasive prenatal testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp

What Trends Will Shape the Non-invasive Prenatal Testing Market Through 2029 and Beyond?
The advancement in next-generation sequencing has improved not only its throughput and speed but also its scalability, providing researchers with a platform to conduct various applications and study biological systems on a greater scale. This technology enables simultaneous sequencing of thousands or even millions of DNA molecules. Manufacturers introduced this technology with the aim of reducing time, cost and to optimize the output to provide accurate results pertaining to genome and DNA testing. Major players in the field like Illumina, Eurofins, Natera, Roche, and Annoroad have incorporated this technology in non-invasive prenatal testing. CFDA (China Food and Drug Administration) has also given its nod for the medical instrument product registration of the NGS instrument NextSeq 550AR created by Annoroad.

What Are the Main Segments in the Non-invasive Prenatal Testing Market?
The non-invasive prenatal testing market covered in this report is segmented -

1) By Type: Consumables, Instruments
2) By Application: Trisomy, Microdeletion, Genetics, Rh factor
3) By End User: Hospital, Diagnostic Labs

Subsegment:
1) By Consumables: Assay Kits, Reagents, Disposables
2) By Instruments: Next-Generation Sequencers (NGS), Polymerase Chain Reaction (PCR) Systems, Ultrasound Devices, Others (Microarrays And Mass Spectrometers)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2492&type=smp

Which Top Companies are Driving Growth in the Non-invasive Prenatal Testing Market?
Major companies operating in the non-invasive prenatal testing market include F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Inc., Agilent Technologies Inc., BGI Diagnosis Co Ltd., Berry Genomics Co, LifeCodexx AG, Myriad Genetics Inc., NIPD Genetics Co Ltd., Sequenom Inc., Annoroad Gene Technology Co Ltd., Centogene AG, Counsyl Inc., EUROFINS Genoma Group, Eurofins Scientific SE, Next Biosciences, Premaitha Health Plc, Ariosa Diagnostics Inc., Beijing Genomics Institute, Yourgene Health PLC, GE Healthcare Technologies Inc., Koninklijke Philips NV, Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., QIAGEN NV, MedGenome Labs Ltd., Progenity Inc.

Which Regions Will Dominate the Non-invasive Prenatal Testing Market Through 2029?
North America was the largest region in the non-invasive prenatal testing market in 2023. Western Europe was the second largest region in the non-invasive prenatal testing market. The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2492

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.